Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03260257 · ClinicalTrials.gov registry record · NA
A Neurofeedback Intervention to Improve Working Memory in Schizophrenia
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT03260257 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 64 participants.
The verdict
NCT03260257, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
Schizophrenia affects 2.4 million Americans and causes significant individual and societal costs. Cognitive deficits including poor working memory arise early in the course of illness, account for poor long-term outcomes and have been difficult to treat with available treatments. The investigators are proposing to develop a novel, computer-based brain training to improve working memory in schizophrenia patients, which, if successful could have significant personal, societal, and economic impact.
Interventions
- OTHER Neurofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03260257
The ClinicalTrials.gov registry entry for NCT03260257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neurofeedback is the first listed.
NCT03260257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03260257 about?
NCT03260257 is a clinical study titled "A Neurofeedback Intervention to Improve Working Memory in Schizophrenia". Schizophrenia affects 2.4 million Americans and causes significant individual and societal costs. Cognitive deficits including poor working memory arise early in the course of illness, account for poor long-term outcomes and have been difficult to treat with available treatments. The investigators a...
What is the current status of trial NCT03260257?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2018-03-01. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT03260257?
The interventions under investigation include: Neurofeedback (OTHER).
Who is sponsoring clinical trial NCT03260257?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.